Phillip Dane Michaels, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Phillip Michaels's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Phillip Michaels has written about over time.
Proto-Oncogene Proteins c-metArthritis, RheumatoidEpstein-Barr Virus InfectionsImmunosuppressive AgentsMethotrexateOral UlcerLymphoma, T-CellLymphoma, T-Cell, PeripheralLeukemia, Myeloid, AcuteHistiocytosisLymphoma, Large-Cell, AnaplasticLymphoma, Large B-Cell, DiffuseCore Binding Factor Alpha 2 SubunitDioxygenasesMyeloproliferative DisordersImmunotherapy, AdoptiveCell Transdifferentiation
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 2018 | March 2018 |
| Arthritis, Rheumatoid | 1 | 2021 | 2021 | March 2021 |
| Epstein-Barr Virus Infections | 1 | 2021 | 2021 | March 2021 |
| Immunosuppressive Agents | 1 | 2021 | 2021 | March 2021 |
| Methotrexate | 1 | 2021 | 2021 | March 2021 |
| Oral Ulcer | 1 | 2021 | 2021 | March 2021 |
| Lymphoma, T-Cell | 1 | 2022 | 2022 | February 2022 |
| Lymphoma, T-Cell, Peripheral | 1 | 2022 | 2022 | February 2022 |
| Leukemia, Myeloid, Acute | 3 | 2019 | 2023 | March 2022 |
| Histiocytosis | 1 | 2022 | 2022 | June 2022 |
| Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 2022 | August 2022 |
| Lymphoma, Large B-Cell, Diffuse | 2 | 2021 | 2024 | November 2022 |
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 2023 | July 2023 |
| Dioxygenases | 1 | 2023 | 2023 | July 2023 |
| Myeloproliferative Disorders | 1 | 2023 | 2023 | July 2023 |
| Immunotherapy, Adoptive | 2 | 2023 | 2024 | February 2024 |
| Cell Transdifferentiation | 1 | 2024 | 2024 | June 2024 |